Large-scale preparation method of hair follicle stem cell functional subpopulation

Through painless, simple operation, non-integrated non-viral iPSCs preparation method, efficiently differentiated into human hair follicle stem cells, solving the problems of limited number of hair follicles and cumbersome operation in hair regeneration technology, and achieving a safe, efficient and non-invasive solution of hair regeneration technology .

CN118995584APending Publication Date: 2024-11-22SHENZHEN LETU DANLUN BIOMEDICINE CO LTD +1
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411104837.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

In the existing hair regeneration technology, drug intervention has side effects and short-acting effects, and hair follicle transplantation is traumatic and cumbersome, resulting in limited number of hair follicle stem cells, limiting the widespread application of hair regeneration technology.

Method used

Using painless, simple-operated non-integrated non-viral, serum-free human hair follicle stem cells (iPSCs), the preparation method is efficiently differentiated into human hair follicle stem cells (HFSCs) through mRNA cocktails and specific medium components, and improved by HFSCs exosomes. Hair follicle growth microenvironment.

Benefits of technology

It realizes high-quality and stable hair follicle stem cell preparation, solves the problems of limited number of hair follicles and cumbersome operation, and provides a safe, efficient and non-invasive solution for hair regeneration.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118995584A_ABST
    Figure CN118995584A_ABST
Patent Text Reader

Abstract

The invention discloses a large-scale preparation method of a hair follicle stem cell functional subpopulation, and belongs to the technical field of biology. According to the large-scale preparation method of the hair follicle stem cell functional subpopulation, a human hair follicle stem cell (HFSCs) differentiation system is optimized, and HFSCs derived from iPSCs differentiation are obtained. According to the method, the HFSCs cell strain which is stable in production process, high in differentiation consistency and high in multiplication capacity can be continuously obtained. The problems that the number of hair follicles is limited, the hair follicles cannot be regenerated and operation is tedious are solved, and a good technical foundation is laid for establishing human hair follicle stem cell (HFSCs) resources of a clinical application level.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biotechnology, and more particularly to a method for large-scale preparation of functional subpopulations of hair follicle stem cells. Background Art

[0002] Currently, relatively effective hair regeneration technologies include drug intervention and hair follicle transplantation.

[0003] There are 6 kinds of commonly used drugs on the market, including minoxidil, finasteride, flutamide, diphenylcyclopropenone, retinoic acid, spironolactone, etc., which correspond to different symptoms. Although drug intervention is effective, it has obvious side effects, the duration of drug effect is short, and it causes great damage to the human body.

[0004] Follicular unit transplantation (FUT) is currently used to transplant hair follicles to a specific area to achieve continuous hair growth. However, this technology has large individual differences in treatment effects and is very traumatic. In particular, the separation of hair follicles from in vivo tissue is cumbersome, the biological activity of hair follicles is low, and the donor hair follicles of hair loss patients are limited and non-regenerative, which limits the widespread application of hair follicle transplantation and hair regeneration technology.

[0005] Therefore, providing a method for large-scale preparation of functional subsets of hair follicle stem cells is an urgent problem to be solved by those skilled in the art. Summary of the invention

[0006] In view of this, the present invention provides a method for large-scale preparation of functional subsets of hair follicle stem cells.

[0007] Hair follicle stem cells have multidirectional differentiation potential, and can differentiate into epidermis, hair follicles, and sebaceous glands, and participate in the process of skin wound healing. The purpose of this invention is to establish a new method for preparing human hair follicle stem cells (HFSCs) with the technical support of the early stage of the project, and to produce hair follicle stem cell biological preparations and their derivatives with uniform and stable activity batches.

[0008] In order to achieve the above object, the present invention adopts the following technical solution:

[0009] Aiming at the technical bottleneck of the existing preparation of human hair follicle stem cells (HFSCs), the present invention has established a painless, simple to operate, stable, infinitely expandable and high-quality HFSCs preparation system. The overall process includes: (1) Establishing a non-integrated, non-viral, serum-free, culture medium-defined, and feeder-free iPSCs cell line. (2) Efficient differentiation of iPSCs into HFSCs. The specific steps are as follows:

[0010] 1) Establish a non-integrating, non-viral, serum-free, culture medium-defined, and feeder-cell-free iPSC cell line.

[0011] The main steps are as follows:

[0012] (1) Stem cell preparation: Umbilical cord-derived mesenchymal stem cells (UMSCs) were resuscitated and cultured using a chemically defined, serum-free, animal-derived component-free MSCs culture medium (Youkang NC0103). When the cell confluence was 70%-80% under a microscope, TrypLE TM Express (Thermo Fisher Scientific), and then the cells were collected after digestion. Then, trypan blue staining (STEMCELL technologies) and cell counter (Countstar) were used to calculate the cell viability. When it was greater than 90%, the cells were plated into 6-well plates pre-coated with 10 μg / well vitronectin (Vitronectin, STEMCELL technologies). A total of 50,000 to 100,000 cells were plated per well, preferably 50,000 cells, and then transferred to a 37°C carbon dioxide incubator for 24 hours.

[0013] (2) Cell transfection: When the cells were observed under a microscope to be 25%-30% confluent, the MSCs culture medium was removed and 1 ml of D-PBS (without Ca) was added. 2+ and Mg 2+ ) and then added 1 ml of MSCs culture medium containing 175 ng / mL B18 factor and returned to the 37°C incubator for 20 minutes. Then, each 6-well plate was evenly dripped with the mRNA cocktail reagent combination (STEMCELL technologies, specifically including 1 μl ReproRNA TM -OKSGM, 100 μl IReduced-Serum Medium, 2μl ReproRNA TM Transfection Supplement and 2μlReproRNA TM Transfection Reagent) and then transferred to a 37°C CO2 incubator for 24 h.

[0014] (3) Drug addition screening: Aspirate the culture medium in the 6-well plate, add 1.5 ml of screening medium (MSCs culture medium + 175 ng / ml B18 factor + 0.8 μg / ml puromycin (Puromycin, STEMCELL technologies), and then transfer to a 37°C carbon dioxide incubator for 24 hours. Change the medium every day and repeat the operation for 2-5 days.

[0015] (4) Drug-free culture: Aspirate the culture medium in the 6-well plate, add 1.5 ml of drug-free culture medium (MSCs culture medium + 175 ng / ml B18 factor), and then transfer to a 37°C carbon dioxide incubator for continued culture. Observe the changes in cell morphology. At this time, cobblestone-like epithelial cells can be observed. Change the medium every day and repeat the operation for 2 days.

[0016] (5) Clone screening: Aspirate the culture medium in the 6-well plate and add 1.5 ml of ReproTeSR TM Culture medium (STEMCELL technologies), transferred to a 37°C CO2 incubator for continued culture, changing the medium every day, and tracking and observing cell morphological changes under a microscope until iPSCs clones appeared (about 2 weeks later).

[0017] (6) Clone picking and identification: Record the shape of the clones under a microscope and take photos to mark them. Use a 10 μl pipette to transfer a single clone to a 12-well plate pre-coated with 5 μg vitronectin and add 1 ml TeSR TM -E8 TM Culture medium (STEMCELL technologies), pipette 10 times with a 1 ml pipette, mark passage 1, and then transfer to a 37 ° C carbon dioxide incubator for further culture. After 3 to 5 days, when the confluence of iPSCs is 80% or above, use ReLeSR TM After iPSCs were digested with digestion solution (STEMCELL technologies), they were passaged and expanded at a dilution ratio of no less than 1:10. After iPSCs cells were cultured to passage 8, quality identification was performed, including: a) cell morphology analysis; b) alkaline phosphatase staining; c) immunofluorescence staining including but not limited to OCT4, SSEA-4 and TRA-1-60; d) embryoid body three-germ layer differentiation; e) teratoma and other experimental identifications to determine that it is a high-quality non-integrated non-viral iPSCs cell model.

[0018] 2) iPSCs are efficiently differentiated into HFSCs.

[0019] The main steps are as follows:

[0020] (1) iPSCs cell preparation: using Essential 8 TM The non-integrated and non-viral iPSCs were revived with culture medium (Gibco) and transferred to a 6-well plate pre-coated with 10 μg vitronectin, and cultured in a 37°C carbon dioxide incubator until the iPSCs cells reached 80% to 90% confluence.

[0021] (2) Embryoid body (EBs) culture: Aspirate and discard Essential 8 TMculture medium, add 1 ml D-PBS (without Ca 2+ and Mg 2 + ) Wash once, 3ml Essential 8 TM Resuspend in culture medium (containing ROCK inhibitor "Y-27632", 1μl / ml), manually divide iPSCs colonies into small clusters; use a P-1000 pipette to pipette up and down several times to reduce the size of the cluster (about 50-100 cells / cluster), transfer to a new 6-well plate, transfer to a 37℃ carbon dioxide incubator and culture for 24 hours. Check EB formation under a microscope the next day and replace with new Essential 8 TM The culture medium (containing ROCK inhibitor "Y-27632", 1 μl / ml) was replaced every day, and the operation was repeated for 2-4 days.

[0022] (3) Inducing HFSCs: After obvious embryoid bodies (EBs) were observed under a microscope, the EBs were collected in a 15 ml conical tube. After removing the supernatant, the EBs were transplanted onto a 6-well plate pre-coated with 48-96 μg collagenase I and cultured in 3 ml HFSCs differentiation medium①, which includes: DMEM / F12 medium (Gibco), supplemented with Insulin (5 μg / ml), Hydrocortisone (0.5 μg / ml), L-AA (L-ascorbic acid, 0.3 mmol / l), Adenine (24 μg / ml), BMP-4 (bone morphogenetic protein 4, 25 ng / ml), ATRA (all-trans retinoic acid, 1 μM) and EGF (recombinant human epidermal growth factor, 20 ng / ml). The medium was changed every day and cultured in a 37°C carbon dioxide incubator for 3 days.

[0023] (4) HFSCs culture: The medium was changed every day in a ratio of HFSCs differentiation medium ①: HFSCs differentiation medium ② of 3:1, 1:1, and 1:3, respectively, and the medium was replaced with HFSCs differentiation medium ②, wherein the components of HFSCs differentiation medium ② include: keratinocyte SFM medium (Gibco) with defined components, BMP-4 (1 ng / ml), and EGF (20 ng / ml). The medium was then changed every day, and transplantable HFSCs cells were obtained by culturing in a 37°C carbon dioxide incubator for 5-7 days.

[0024] (5) Identification of HFSCs: After expansion, HFSCs are identified, including but not limited to the following identifications: a) cell morphology identification; b) identification of HFSCs functional subpopulations by immunofluorescence staining of keratin 18 (KRT18), transcription factor p63, keratin 14 (KRT14), and integrin β1 (ITGβ1); c) identification of stability in subsequent generations by fluorescent staining of keratin 18 and transcription factor p63 to determine whether it is a high-quality HFSCs cell model.

[0025] 3) High-purity HFSCs exosome extraction:

[0026] The culture supernatant of HFSCs of passages 4-6 was collected, centrifuged at 4°C 300g for 5-10 minutes, and supernatant ① was collected; supernatant ① was centrifuged at 4°C 2000g-3000g for 10 minutes, and supernatant ② was collected; supernatant ② was centrifuged at 4°C 7000-10000g for 10 minutes, and supernatant ③ was collected; supernatant ③ was centrifuged at 4°C 100000g for 70 minutes, and supernatant ④ was collected; supernatant ④ was centrifuged at 4°C 100000g for 70 minutes, and the supernatant was discarded. 3-5 ml of the bottom was collected per liter of supernatant to obtain exosomes.

[0027] Furthermore, the method described above prepares functional subpopulations of hair follicle stem cells.

[0028] Furthermore, the hair follicle stem cell functional subsets are used in hair regeneration.

[0029] Furthermore, the HFSCs exosomes prepared by the method described above are obtained.

[0030] Furthermore, the HFSCs exosomes are used in hair regeneration.

[0031] It can be seen from the above technical solutions that compared with the prior art, the present invention discloses a method for the large-scale preparation of functional subsets of hair follicle stem cells. First, a method for preparing human induced pluripotent stem cells (iPSCs) without feeder layer and serum is established using mRNA cocktails. This method does not require feeder layer cells and fetal bovine serum, the culture medium components are clear, the operation is simple, there is no risk of exogenous genome integration, and human iPSCs cell lines can be prepared efficiently and stably. Secondly, the human hair follicle stem cell (HFSCs) differentiation system is optimized to obtain HFSCs derived from iPSCs differentiation. This method can continuously obtain HFSCs cell lines with stable production process, high differentiation consistency, strong proliferation ability, high expression of hair follicle stem cell markers KRT18, ITGβ1, p63 and low expression of marker KRT14. It solves the problems of limited number of hair follicles, non-renewable and cumbersome operation, and lays a good technical foundation for establishing human hair follicle stem cell (HFSCs) resources at the clinical application level. Finally, after culturing HFSCs, high-purity exosomes derived from HFSCs can be obtained, which can be used to improve the microenvironment of hair follicle growth and promote hair regeneration. This method is safe, efficient, non-invasive, low-cost, easy to use and drug. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on the provided drawings without paying creative work.

[0033] Figure 1 The accompanying drawing shows the appearance of cobblestone epithelial cell clones of the present invention;

[0034] Figure 2 The accompanying drawings show the appearance of iPSCs clones of the present invention;

[0035] Figure 3 The accompanying drawings show the iPSCs cells of the present invention;

[0036] Figure 4 The accompanying drawings are embryoid bodies (EBs) of the present invention;

[0037] Figure 5 The accompanying drawings show the HFSCs cells of the present invention;

[0038] Figure 6 The accompanying drawing shows the identification of HFSCs functional subpopulations by immunofluorescence staining of the present invention;

[0039] Figure 7 The accompanying drawing is a flow cytometric graph of the stability of HFSCs passage according to the present invention;

[0040] Among them, Figure A and Figure B are the 4th generation HFSCs, and Figure C and Figure D are the 8th generation HFSCs;

[0041] Figure 8 The attached figure is an electron microscope image of exosomes derived from HFSCs of the present invention. DETAILED DESCRIPTION

[0042] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0043] If no specific technology or conditions are specified in the examples of the present invention, they can be obtained through conventional channels such as market purchase, and the method flow can refer to the reagent or equipment description.

[0044] Example 1 Establishment of clinical-grade human iPSCs cell lines

[0045] (1) Stem cell preparation: Umbilical cord-derived mesenchymal stem cells (UMSCs) were resuscitated and cultured using a chemically defined, serum-free, animal-derived component-free MSCs culture medium (Youkang NC0103). When the cell confluence was 70%-80% under a microscope, TrypLE TM Express (Thermo Fisher Scientific) digestion, the cells were collected, and then the cell viability was calculated by trypan blue staining (STEMCELL technologies) and cell counter (Countstar). When the cell viability was greater than 90%, the cells were plated into 6-well plates pre-coated with 10 μg / well vitronectin (Vitronectin, STEMCELL technologies), 50,000 cells were plated per well, and then transferred to a 37°C carbon dioxide incubator for culture for 24 h.

[0046] (2) Cell transfection: When the cells were observed under a microscope to be 25%-30% confluent, the MSCs culture medium was removed and 1 ml of D-PBS (Gibco, without Ca2+) was added. 2+ and Mg 2+) was washed once, and then 1 ml of MSCs culture medium containing 175 ng / mL B18 factor (STEMCELL technologies) was added and placed in a 37°C carbon dioxide incubator for 20 minutes. Then, mRNA cocktails reagent combination (STEMCELL technologies, specifically including 1 μl ReproRNA TM -OKSGM, 100 μl I Reduced-Serum Medium, 2μlReproRNA TM Transfection Supplement and 2μl ReproRNA TM Transfection Reagent) and then transferred to a 37°C CO2 incubator for 24 h.

[0047] (3) Drug addition screening: Aspirate the culture medium in the 6-well plate, add 1.5 ml of screening medium (MSCs culture medium + 175 ng / ml B18 factor + 0.8 μg / ml puromycin (STEMCELL technologies)), and then transfer to a 37°C carbon dioxide incubator for 24 hours. Change the medium every day and repeat the operation for 5 days.

[0048] (4) Drug-free culture: Aspirate the culture medium in the 6-well plate, add 1.5 ml of drug-free culture medium (MSCs culture medium + 175 ng / ml B18 factor), and then transfer to a 37°C carbon dioxide incubator for continued culture. Observe the changes in cell morphology. At this time, cobblestone epithelial cells can be observed ( Figure 1 ), changing the medium every day, and repeating the operation for 2 days.

[0049] (5) Clone screening: Aspirate the culture medium in the 6-well plate and add 1.5 ml of ReproTeSR TM Culture medium (STEMCELL technologies), transferred to a 37°C CO2 incubator for continued culture, changing the medium every day, and tracking cell morphology changes under a microscope until iPSCs clones appeared ( Figure 2 )(about 2 weeks later).

[0050] (6) Clone picking and identification: Record the shape of the clones under a microscope and take photos to mark them. Use a 10 μl pipette to transfer a single clone to a 12-well plate pre-coated with 5 μg vitronectin and add 1 ml TeSR TM -E8 TMCulture medium (STEMCELL technologies), pipette 10 times with a 1 ml pipette, mark passage 1, and then transfer to a 37 ° C carbon dioxide incubator for further culture. After 5 days, when the confluence of iPSCs is 80% or above, use ReLeSR TM After iPSCs were digested with digestion solution (STEMCELL technologies), they were passaged and expanded at a dilution ratio of no less than 1:10. After iPSCs cells were cultured to passage 8, quality identification was performed, including: a) cell morphology analysis; b) alkaline phosphatase staining; c) immunofluorescence staining including but not limited to OCT4, SSEA-4 and TRA-1-60; d) embryoid body three-germ layer differentiation; e) teratoma and other experimental identifications to determine that it is a high-quality non-integrated non-viral iPSCs cell model.

[0051] Example 2 iPSCs are efficiently differentiated into HFSCs.

[0052] (1) iPSCs cell preparation: using Essential 8 TM Non-integrated non-viral iPSCs were revived with culture medium (Gibco) in a 6-well plate pre-coated with 10 μg vitronectin, and then transferred to a 37°C carbon dioxide incubator and cultured until the iPSCs cells reached 80% to 90% confluence ( Figure 3 ).

[0053] (2) Embryoid body (EBs) culture: Aspirate and discard Essential 8 TM Culture medium, add 1 ml D-PBS (Gibco, without Ca 2 + and Mg 2+ ) Wash once, 3ml Essential 8 TM Resuspend in culture medium (containing ROCK inhibitor "Y-27632", STEMCELLtechnologies, 1μl / ml), manually divide iPSCs colonies into small clusters; use a P-1000 pipette to pipette up and down several times to reduce the size of the cluster (about 50-100 cells / cluster), transfer to a new 6-well plate, transfer to a 37℃ carbon dioxide incubator and culture for 24 hours. Check EB formation under a microscope the next day and replace with new Essential 8 TM The culture medium (containing ROCK inhibitor "Y-27632", 1 μl / ml) was replaced every day and the operation was repeated for 4 days.

[0054] (3) Induction of HFSCs: After the obvious spherical embryoid bodies (EBs) were observed under a microscope ( Figure 4), collect EBs in a 15 ml conical tube, remove the supernatant, and transplant EBs onto a 6-well plate pre-coated with 50 μg collagenase I (STEMCELL technologies), and culture them with 3 ml HFSCs differentiation medium ①. Change the medium every day, and culture them in a 37°C carbon dioxide incubator for 3 days. EBs can be observed to adhere to the wall and cells migrate out from the edge. HFSCs differentiation medium ① includes: DMEM / F12 medium (Gibco), supplemented with Insulin (Sigma-Aldrich, 5 μg / ml), Hydrocortisone (STEMCELL technologies, 0.5 μg / ml), L-AA (MEC, 0.3 mmol / l), Adenine (Sigma-Aldrich, 24 μg / ml), BMP-4 (STEMCELL technologies, 25 ng / ml), ATRA (MEC, 1 μM) and EGF (STEMCELL technologies, 20 ng / ml).

[0055] (4) HFSCs culture: The medium was changed every day at a ratio of 3:1, 1:1, and 1:3, and the HFSCs differentiation medium ① was gradually replaced with the HFSCs differentiation medium ②, wherein the components of the HFSCs differentiation medium ② included: a defined keratinocyte SFM medium (Gibco), BMP-4 (1 ng / ml), and EGF (20 ng / ml). After that, the HFSCs differentiation medium ② was replaced with freshly prepared HFSCs differentiation medium every day, and transplantable HFSCs cells were obtained by culturing in a 37°C carbon dioxide incubator for 5-7 days. Figure 5 ).

[0056] (5) HFSCs identification: When the cell confluence of the induced HFSCs was 70%-80% under microscope, the cells were identified by using TrypLE TM After digestion with 1% Fermented Protein Express (Thermo Fisher Scientific), HFSCs were collected and transferred to a new 6-well plate at a dilution ratio of 1:2, marked as passage 1, and then transferred to a 37°C carbon dioxide incubator for continued culture; thereafter, the cells were passaged to passage 10 at a dilution ratio of no less than 1:2. After amplification, HFSCs were identified, including but not limited to the following: a) cell morphology identification ( Figure 5); b) Immunofluorescence staining of keratin 18 (KRT18, abcam), transcription factor p63 (abcam), keratin 14 (KRT14, abcam), and integrin β1 (ITGβ1, abcam) was used to obtain functional subpopulations of HFSCs with high expression of hair follicle stem cell markers KRT18, ITGβ1, and p63 and low expression of marker KRT14 ( Figure 6 c) Passage stability identification: HFSCs of passage 4 and passage 8 were selected, and flow cytometry was performed after fluorescence staining of keratin 18 (KRT18, abcam) and transcription factor p63 (abcam) ( Figure 7 ). Figure 7 In the figure, Figure A and Figure B are the 4th generation HFSCs, and Figure C and Figure D are the 8th generation HFSCs; the results show that the HFSCs cells with high expression of KRT18 in Figure A and Figure C are both above 90%, and the HFSCs cells with high expression of p63 in Figure B and Figure D are both above 90%; the figure shows that the HFSCs are passaged from the 1st generation to the 8th generation, and the cell phenotype is stable and the differentiation consistency is high.

[0057] Example 3 High-purity HFSCs exosome extraction

[0058] The supernatant of the 5th generation HFSCs culture medium (abbreviated as supernatant) was collected and centrifuged at 4°C 300g for 5 minutes to remove live cells and collect supernatant ①; supernatant ① was centrifuged at 4°C 2000g for 10 minutes to remove dead cells and collect supernatant ②; supernatant ② was centrifuged at 4°C 10000g for 10 minutes to remove cell debris and collect supernatant ③; supernatant ③ was centrifuged at 4°C 100000g for 70 minutes to remove larger vesicles and collect supernatant ④; supernatant ④ was centrifuged at 4°C 100000g for 70 minutes, the supernatant was discarded, and 3 ml of the bottom of each liter of supernatant was collected to obtain HFSCs exosomes ( Figure 8 ).

[0059] In summary, the present invention has established a clinical-grade HFSCs preparation method for the first time. First, mRNA cocktails, including pluripotency genes Oct-3 / 4, Klf-4, Sox2, Glis1, c-Myc and resistance gene puromycin protein coding sequences, are used to trigger the activation of the endogenous pluripotency gene network of cells through the expression of exogenous pluripotency genes, and then puromycin drugs are used to screen and remove cells that have not been successfully reprogrammed, thus establishing a feeder-free and serum-free method for preparing human induced pluripotent stem cells. This method does not require feeder cells and fetal bovine serum, the culture medium components are clear, the operation is simple, there is no risk of exogenous genome integration, and human iPSCs cell lines can be prepared efficiently and stably. Secondly, according to the existing research results, it was found that specific factors have an important role in promoting and maintaining the differentiation of HFSCs. Therefore, the HFSCs derived from iPSCs differentiation have high differentiation consistency, significantly improved proliferation ability, high expression of KRT18, ITGβ1, p63, low expression of KRT14 and other significant hair follicle stem cell characteristics. After large-scale amplification of HFSCs, the detection showed that the hair follicle stem cell characteristics of HFSCs cells after passage were stably expressed and uniform. In addition, due to the unlimited proliferation characteristics of iPSCs, HFSCs with stable production processes from their sources will be continuously obtained, laying a good technical foundation for the establishment of human HFSCs cell resources at the clinical application level. Finally, after culturing HFSCs, high-purity HFSCs-derived exosomes can be obtained, which are used to improve the microenvironment of hair follicle growth and promote hair regeneration. This method is safe, efficient, non-invasive, easy to operate, low-priced, and has high drugability and is easier to use clinically.

[0060] The above description of the disclosed embodiments enables those skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.

Claims

1. A method for large-scale preparation of functional subsets of hair follicle stem cells, characterized in that: The specific steps are as follows: 1) Establish a non-integrating, non-viral, serum-free, culture medium with defined components, and feeder-free iPSC cell line; 2) Efficient differentiation of iPSCs into HFSCs; the steps are as follows: (1) iPSCs cell preparation: using Essential 8 TM The non-integrated and non-viral iPSCs were revived in the culture medium and placed in a 6-well plate pre-coated with 10 μg vitronectin, and cultured in a 37°C carbon dioxide incubator until the iPSCs cells reached 80% to 90% confluence; (2) Embryoid body culture: Aspirate and discard Essential 8 TM Add 1 ml of culture medium without Ca 2+ and Mg 2+ Wash once with D-PBS, 3 ml Essential 8 TM Resuspend the culture medium and manually separate the iPSCs colonies into small clusters; use a P-1000 pipette to pipette up and down several times to reduce the size of the clusters, transfer to a new 6-well plate, transfer to a 37°C carbon dioxide incubator and culture for 24 hours; check the EB formation under a microscope the next day and replace with a new Essential 8 TM The culture medium was changed every day, and the operation was repeated for 2-4 days; the Essential 8 TM The culture medium contained ROCK inhibitor "Y-27632", 1 μl / ml; (3) Inducing HFSCs: After obvious embryoid bodies (EBs) were observed under a microscope, the EBs were collected in a 15 ml conical tube. After removing the supernatant, the EBs were transplanted onto a 6-well plate pre-coated with 48-96 μg collagenase I and cultured in 3 ml HFSCs differentiation medium①. The medium was changed every day and cultured in a 37°C carbon dioxide incubator for 3 days. (4) HFSCs culture: The medium was changed every day at a ratio of HFSCs differentiation medium ①: HFSCs differentiation medium ② of 3:1, 1:1, and 1:3 respectively, and the medium was replaced with HFSCs differentiation medium ②; the medium was then changed every day, and transplantable HFSCs cells were obtained by culturing in a 37°C carbon dioxide incubator for 5-7 days; (5) HFSCs identification: When the cell confluence of the induced HFSCs was 70%-80% under microscope, the cells were identified by TrypLE TM After express digestion, HFSCs cells were collected and transferred into a new 6-well plate at a dilution ratio of 1:2, marked as passage 1, and then transferred to a 37°C carbon dioxide incubator for continued culture; thereafter, the cells were passaged to passage 10 at a dilution ratio of not less than 1:

2. The amplified HFSCs were identified, including but not limited to the following: a) cell morphology identification; b) HFSCs functional subpopulation identification by immunofluorescence staining of keratin 18, transcription factor p63, keratin 14, and integrin β1; c) keratin 18 and transcription factor p63 fluorescence staining for passage stability identification.

2. The method for large-scale preparation of hair follicle stem cell functional subsets according to claim 1, characterized in that: The steps of establishing a non-integrated, non-viral, serum-free, culture medium-defined, feeder-cell-free iPSCs cell line in step 1) are as follows: (1) Stem cell preparation: Umbilical cord-derived mesenchymal stem cells were revived and cultured using a chemically defined, serum-free, animal-free MSCs culture medium. When the cell confluence was 70%-80% under a microscope, TrypLE TM After Express digestion, cells were collected and then calculated using trypan blue staining and a cell counter. When the cell viability was greater than 90%, the cells were plated into a 6-well plate pre-coated with 10 μg / well vitronectin, with a total of 50,000 to 100,000 cells per well, and then transferred to a 37°C CO2 incubator for 24 h; (2) Cell transfection: When the cells are 25%-30% confluent under a microscope, remove the MSCs culture medium and add 1 ml of Ca-free 2+ and Mg 2+ The plates were washed once with D-PBS, and then 1 ml of MSCs culture medium containing 175 ng / mL B18 factor was added and returned to the 37°C incubator for 20 minutes. The mRNA cocktail reagent combination was then evenly added to each 6-well plate after being placed at room temperature for 5 minutes. The plates were then transferred to a 37°C carbon dioxide incubator for 24 hours. The mRNA cocktail reagent combination included 1 μl of ReproRNA TM -OKSGM, 100 μl I Reduced-Serum Medium, 2μlReproRNA TM Transfection Supplement and 2μl ReproRNA TM Transfection Reagent; (3) Drug addition screening: aspirate the medium in the 6-well plate, add 1.5 ml of screening medium, and then transfer to a 37°C carbon dioxide incubator for 24 hours, change the medium every day, and repeat the operation for 2-5 days; the screening medium is MSCs medium + 175 ng / ml B18 factor + 0.8 μg / ml puromycin; (4) Drug-free culture: aspirate the medium in the 6-well plate, add 1.5 ml of drug-free medium, and then transfer to a 37°C carbon dioxide incubator for continued culture to observe changes in cell morphology. At this time, cobblestone-like epithelial cells can be observed. Change the medium every day and repeat the operation for 2 days; the drug-free medium is MSCs medium + 175 ng / ml B18 factor; (5) Clone screening: Aspirate the culture medium in the 6-well plate and add 1.5 ml of ReproTeSR TM The culture medium was transferred to a 37°C CO2 incubator for continued culture, with the medium changed every day. Cell morphology changes were tracked and observed under a microscope until iPSCs clones appeared; (6) Clone picking and identification: Record the shape of the clones under a microscope and take photos to mark them. Use a 10 μl pipette to transfer a single clone to a 12-well plate pre-coated with 5 μg vitronectin and add 1 ml TeSR TM -E8 TM The culture medium was pipetted 10 times with a 1 ml pipette, marked as passage 1, and then transferred to a 37°C carbon dioxide incubator for continued culture; after 3 to 5 days, when the confluence of iPSCs was 80% or above, ReLeSR TM After iPSCs were digested with digestion solution, they were subcultured and expanded at a dilution ratio of no less than 1:10; After iPSCs cells were cultured to passage 8, quality identification was performed, including: a) cell morphology analysis; b) alkaline phosphatase staining; c) immunofluorescence staining including but not limited to OCT4, SSEA-4 and TRA-1-60; d) embryoid body three-germ layer differentiation; e) teratoma experimental identification to determine that it is a high-quality non-integrated and non-viral iPSCs cell model.

3. The method for large-scale preparation of hair follicle stem cell functional subsets according to claim 1, characterized in that: The HFSCs differentiation medium ① comprises: DMEM / F12 medium, supplemented with 5 μg / ml Insulin, 0.5 μg / ml Hydrocortisone, 0.3 mmol / l L-AA, 24 μg / ml Adenine, 25 ng / ml BMP-4, 1 μM ATRA and 20 ng / ml EGF.

4. The method for large-scale preparation of hair follicle stem cell functional subsets according to claim 1, characterized in that: The HFSCs differentiation medium ② comprises: a keratinocyte SFM medium with defined components, supplemented with 1 ng / ml BMP-4 and 20 ng / ml EGF.

5. The functional subpopulation of hair follicle stem cells prepared by the method according to any one of claims 1 to 4.

6. Use of the hair follicle stem cell functional subset according to claim 5 in hair regeneration.

7. A method for preparing HFSCs exosomes, characterized in that: The following steps are involved: The culture supernatant of HFSCs of passages 4-6 was collected, centrifuged at 4°C 300g for 5-10 minutes, and supernatant ① was collected; supernatant ① was centrifuged at 4°C 2000g-3000g for 10 minutes, and supernatant ② was collected; supernatant ② was centrifuged at 4°C 7000-10000g for 10 minutes, and supernatant ③ was collected; supernatant ③ was centrifuged at 4°C 100000g for 70 minutes, and supernatant ④ was collected; supernatant ④ was centrifuged at 4°C 100000g for 70 minutes, and the supernatant was discarded. 3-5 ml of the bottom can be collected for each liter of supernatant to obtain exosomes.

8. HFSCs exosomes prepared by the method according to claim 7.

9. Use of the HFSCs exosomes according to claim 8 in hair regeneration.

Citation Information

Cited By

  • Preparation method of hair follicle stem cells

    CN120988985A